These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Temporal profile and prognostic value of Lp-PLA2 mass and activity in the acute stroke setting. Delgado P; Chacón P; Penalba A; Pelegrí D; Merino C; Ribó M; Rubiera M; Álvarez-Sabin J; Montaner J Atherosclerosis; 2012 Feb; 220(2):532-6. PubMed ID: 22153151 [TBL] [Abstract][Full Text] [Related]
4. Low levels of high-density lipoprotein cholesterol in patients with atherosclerotic stroke: a prospective cohort study. Yeh PS; Yang CM; Lin SH; Wang WM; Chen PS; Chao TH; Lin HJ; Lin KC; Chang CY; Cheng TJ; Li YH Atherosclerosis; 2013 Jun; 228(2):472-7. PubMed ID: 23618097 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein phospholipase A2 mass and activity are not associated with the diagnosis of acute brain ischemia. Tai W; Garcia M; Mlynash M; Kemp S; Albers GW; Olivot JM Cerebrovasc Dis; 2014; 38(5):324-7. PubMed ID: 25428761 [TBL] [Abstract][Full Text] [Related]
6. Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA. Cucchiara BL; Messe SR; Sansing L; MacKenzie L; Taylor RA; Pacelli J; Shah Q; Kasner SE Stroke; 2009 Jul; 40(7):2332-6. PubMed ID: 19461040 [TBL] [Abstract][Full Text] [Related]
7. Prediction of early stroke recurrence in transient ischemic attack patients from the PROMAPA study: a comparison of prognostic risk scores. Purroy F; Jiménez Caballero PE; Gorospe A; Torres MJ; Alvarez-Sabin J; Santamarina E; Martínez-Sánchez P; Cánovas D; Freijo MM; Egido JA; Girón JM; Ramírez-Moreno JM; Alonso A; Rodríguez-Campello A; Casado I; Delgado-Medeiros R; Martí-Fàbregas J; Fuentes B; Silva Y; Quesada H; Cardona P; Morales A; de la Ossa N; García-Pastor A; Arenillas JF; Segura T; Jiménez C; Masjuán J; Cerebrovasc Dis; 2012; 33(2):182-9. PubMed ID: 22237056 [TBL] [Abstract][Full Text] [Related]
8. Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up. Rallidis LS; Tellis CC; Lekakis J; Rizos I; Varounis C; Charalampopoulos A; Zolindaki M; Dagres N; Anastasiou-Nana M; Tselepis AD J Am Coll Cardiol; 2012 Nov; 60(20):2053-60. PubMed ID: 23083783 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of lipoprotein-associated phospholipase A Han L; Zhong C; Bu X; Xu T; Wang A; Peng Y; Xu T; Wang J; Peng H; Li Q; Ju Z; Geng D; Zhang Y; He J; Atherosclerosis; 2017 Nov; 266():1-7. PubMed ID: 28934604 [TBL] [Abstract][Full Text] [Related]
10. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects. Persson M; Hedblad B; Nelson JJ; Berglund G Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184 [TBL] [Abstract][Full Text] [Related]
11. Association of Lp-PLA2-A and early recurrence of vascular events after TIA and minor stroke. Lin J; Zheng H; Cucchiara BL; Li J; Zhao X; Liang X; Wang C; Li H; Mullen MT; Johnston SC; Wang Y; Wang Y; Neurology; 2015 Nov; 85(18):1585-91. PubMed ID: 26311748 [TBL] [Abstract][Full Text] [Related]
12. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study. Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022 [TBL] [Abstract][Full Text] [Related]
13. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments. Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135 [TBL] [Abstract][Full Text] [Related]
14. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker. Corson MA; Jones PH; Davidson MH Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871 [TBL] [Abstract][Full Text] [Related]
15. Serum angiotensin-converting enzyme and recurrent vascular events. The SMART-MR study. Jochemsen HM; Geerlings MI; Visseren FL; Algra A; van der Graaf Y; Muller M; Atherosclerosis; 2012 Oct; 224(2):486-91. PubMed ID: 22884917 [TBL] [Abstract][Full Text] [Related]
16. Intracranial arterial calcification can predict early vascular events after acute ischemic stroke. Lee JG; Lee KB; Roh H; Ahn MY; Bae HJ; Lee JS; Woo HY; Hwang HW J Stroke Cerebrovasc Dis; 2014; 23(5):e331-7. PubMed ID: 24560247 [TBL] [Abstract][Full Text] [Related]
17. Phospholipase A2 in patients with noncardioembolic ischemic stroke and severe inflammatory reaction. Cojocaru IM; Cojocaru M; Tănăsescu R; Iliescu I; Dumitrescu L; Burcin C; Gurban CV; Sfrijan F Rom J Intern Med; 2009; 47(1):61-5. PubMed ID: 19886071 [TBL] [Abstract][Full Text] [Related]
18. Lipoprotein-associated phospholipase A2 and risk of stroke. Gorelick PB Am J Cardiol; 2008 Jun; 101(12A):34F-40F. PubMed ID: 18549870 [TBL] [Abstract][Full Text] [Related]
19. Link between lipoprotein-associated phospholipase A2 gene expression of peripheral-blood mononuclear cells and prognostic outcome after acute ischemic stroke. Tsai TH; Chen YL; Lin HS; Liu CF; Chang HW; Lu CH; Chang WN; Chen SF; Wu CJ; Leu S; Ko SF; Yip HK J Atheroscler Thromb; 2012; 19(6):523-31. PubMed ID: 22447189 [TBL] [Abstract][Full Text] [Related]